Red Ridge Bio
3 known investors
RedRidge Bio discovers and develops biparatopic antibodies (antibodies that bind two sites on a single protein), including biparatopic antibody-drug conjugates, as therapeutics for oncology and autoimmune diseases. The company uses high-throughput technologies and structural/disease biology to engineer and select antibody candidates for liquid and solid tumors and for inflammatory and autoimmune conditions.
Founders & leadership
BS
Bill SellersScientific Founder and Director Cancer Program, Broad Institute
SY
Stephen YoderPresident & CEO
Investors · 3
Frequently asked questions
- What does Red Ridge Bio do?
- RedRidge Bio discovers and develops biparatopic antibodies (antibodies that bind two sites on a single protein), including biparatopic antibody-drug conjugates, as therapeutics for oncology and autoimmune diseases. The company uses high-throughput technologies and structural/disease biology to engineer and select antibody candidates for liquid and solid tumors and for inflammatory and autoimmune conditions.
- Who founded Red Ridge Bio?
- Red Ridge Bio was founded by Bill Sellers.
- Who are Red Ridge Bio's investors?
- Red Ridge Bio's investors include New Enterprise Associates (NEA), Versant Ventures, Sixty Degree Capital.